medroxyprogesterone has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, T; Howes, LG; Manwaring, P; Phoon, S | 1 |
| Wilson, PW | 1 |
| Arranto, AJ; Keinänen, K; Kerola, T; Saarni, HU; Sotaniemi, EA; Stengård, JH; Sutinen, S | 1 |
| Campbell, LV; Hayward, CS; Kelly, RP; Samaras, K; Sullivan, D | 1 |
2 trial(s) available for medroxyprogesterone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of hormone replacement therapy on cardiovascular responses in postmenopausal women with and without type 2 diabetes.
Topics: Administration, Oral; Angiotensin II; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Norepinephrine; Postmenopause; Stress, Physiological; Treatment Outcome | 2002 |
Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Composition; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipid Metabolism; Medroxyprogesterone; Middle Aged; Postmenopause; Risk Factors; Sexual Behavior | 1999 |
2 other study(ies) available for medroxyprogesterone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Lower diabetes risk with hormone replacement therapy: an encore for estrogen?
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Humans; Medroxyprogesterone; Postmenopause; Risk Factors | 2003 |
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.
Topics: Aged; Antipyrine; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Enzyme Induction; Female; Glipizide; Glucose-6-Phosphatase; Humans; Liver; Liver Glycogen; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Microsomes, Liver; Middle Aged; Phenobarbital | 1984 |